Company intelligence / Profile preview

Lazarus Pharmaceuticals

King of Prussia, Pennsylvania, United Stateslazaruspharma.com ↗

Ownership: Private
Development stage: Other

Overview

Lazarus Pharmaceuticals is a clinical-stage pharmaceutical development company focused on identifying and advancing innovative therapies for diseases with unmet medical needs. Their business model centers around acquiring early-stage or dormant late-stage assets, forming independent portfolio companies for each asset, and advancing them through clinical development—primarily up to Phase II—before seeking partnerships or further commercialization opportunities

Therapeutic areas: GastroenterologyEndocrinologyOncology
Modalities: Small molecule (inferred from focus on pharmaceutical development and repurposing of compounds)
Industry: Biotech

Partnerships

Not publicly disclosed.

Beyond the preview

Go deeper on Lazarus Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lazarus Pharmaceuticals.

Explore the full profile